Techniques: Application of systems biology to absorption, distribution, metabolism, excretion and toxicity

被引:120
作者
Ekins, S [1 ]
Nikolsky, Y [1 ]
Nikolskaya, T [1 ]
机构
[1] GeneCo, St Joseph, MI 49085 USA
关键词
D O I
10.1016/j.tips.2005.02.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is widely recognized that either predicting or determining the absorption, distribution, metabolism, excretion and toxicity (ADME/Tox) properties of molecules helps to prevent the failure of some compounds before they reach the clinic. Consequently, there has been considerable research into developing better in silico, in vitro and in vivo methods and models. Toxicogenomics, proteomics, metabonomics and pharmacogenomics represent the latest experimental approaches that can be combined with high-throughput molecular screening of targets to provide a view of the complete biological system that is modulated by a compound. The functional interpretation and relevance of these complex multidimensional data to the phenotype observed in humans is the focus of current research in toxicology. Multiple content databases, data mining and predictive modeling algorithms, visualization tools, and high-throughput data-analysis solutions are being integrated to form systems-ADME/Tox. In this review, we focus on the most recent advances and applications in this area.
引用
收藏
页码:202 / 209
页数:8
相关论文
共 74 条
[1]   Mass spectrometry-based proteomics [J].
Aebersold, R ;
Mann, M .
NATURE, 2003, 422 (6928) :198-207
[2]   Proteome and proteomics: New technologies, new concepts, and new words [J].
Anderson, NL ;
Anderson, NG .
ELECTROPHORESIS, 1998, 19 (11) :1853-1861
[3]   Network biology:: Understanding the cell's functional organization [J].
Barabási, AL ;
Oltvai, ZN .
NATURE REVIEWS GENETICS, 2004, 5 (02) :101-U15
[4]   Interactions of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen with P-glycoprotein and CYP3A [J].
Bekaii-Saab, TS ;
Perloff, MD ;
Weemhoff, JL ;
Greenblatt, DJ ;
von Moltke, LL .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2004, 25 (07) :283-289
[5]   Systematic discovery of multicomponent therapeutics [J].
Borisy, AA ;
Elliott, PJ ;
Hurst, NW ;
Lee, MS ;
Lehár, J ;
Price, ER ;
Serbedzija, G ;
Zimmermann, GR ;
Foley, MA ;
Stockwell, BR ;
Keith, CT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7977-7982
[6]   New methods in predictive metabolism [J].
Boyer, S ;
Zamora, I .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2002, 16 (5-6) :403-413
[7]   Early prediction of drug metabolism and toxicity: systems biology approach and modeling [J].
Bugrim, A ;
Nikolskaya, T ;
Nikolsky, Y .
DRUG DISCOVERY TODAY, 2004, 9 (03) :127-135
[8]   Toxicogenomics: a new revolution in drug safety [J].
Castle, AL ;
Carver, MR ;
Mendrick, DL .
DRUG DISCOVERY TODAY, 2002, 7 (13) :728-736
[9]   Data-driven computer simulation of human cancer cell [J].
Christopher, R ;
Dhiman, A ;
Fox, J ;
Gendelman, R ;
Haberitcher, T ;
Kagle, D ;
Spizz, G ;
Khalil, IG ;
Hill, C .
APPLICATIONS OF BIOINFORMATICS IN CANCER DETECTION, 2004, 1020 :132-153
[10]   Integrative biological analysis of the APOE*3-Leiden transgenic mouse [J].
Clish, CB ;
Davidov, E ;
Oresic, M ;
Plasterer, TN ;
Lavine, G ;
Londo, T ;
Meys, M ;
Snell, P ;
Stochaj, W ;
Adourian, A ;
Zhang, X ;
Morel, N ;
Neumann, E ;
Verheij, E ;
Vogels, JTWE ;
Havekes, LM ;
Afeyan, N ;
Regnier, F ;
Van Der Greef, J ;
Naylor, S .
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2004, 8 (01) :3-13